Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

Completed

Conditions studied: Renal Transplantation

In brief

The goal of the study is to find out the effects of two different drugs used at the beginning of organ transplantation on different populations of immune cells in the body of patients.

Key facts

Study ID

NCT00842699

Run by

Brigham and Women's Hospital

People needed

40

Starts

2008-09-01

Expected to finish

2011-03-01

Last updated by the study team

2011-06-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• all patients considered for transplantation

You may not qualify if…

• none

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.